MedTrace Logo

Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer

NCT01400399 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2015-12-09

No results posted yet for this study

Summary

This study will evaluate the cosmetic outcome and examine factors contributing to cosmetic outcome in women treated with lumpectomy or bilateral breast reduction mammoplasty/mastopexy (BRM) followed by hypofractionated whole breast irradiation. Breast conservation is now an established method of treatment for early breast cancer. Because breast conservation is essentially a cosmetic alternative to mastectomy, quality of life, cosmetic outcome and tumor control are all important considerations during comprehensive treatment planning. Irradiation schemes have been demonstrated to be efficacious and with excellent short term cosmetic outcomes. However, their interaction with currently evolving surgical techniques needs to be examined in order to maintain optimal local control while preserving cosmetic outcome.

Conditions

  • Breast Carcinoma

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • New Hanover Regional Medical Center

    collaborator OTHER

  • Coastal Carolina Radiation Oncology

    lead OTHER

Principal Investigators

  • Michael Nichols, MD, PhD · Coastal Carolina Radiation Oncology

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2016-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01400399 on ClinicalTrials.gov